Today in Banking: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Banking.

Press releases published on September 3, 2026

Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
Electra to Showcase Growing North American Critical Minerals Platform at September Investor and Industry Conferences
Kobo Resources Extends Gold Mineralisation to the North at Kossou with Multiple High-Grade Drill Intercepts
Morocco Strategic Minerals Corp. Completes Sale of Initial 51% Interest in Sakami Property in Québec
Corporation de Minéraux Stratégiques du Maroc réalise la vente d’une participation initiale de 51 % dans la propriété Sakami au Québec
Ressources Kobo étend la minéralisation aurifère vers le nord à Kossou grâce à plusieurs intersections de forage à haute teneur
Volatus Aerospace Selected for Canada’s Defence Drone Initiative Marketplace
Hillman Completes Acquisition of Kanebridge
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
Volatus Aerospace se qualifie pour le Marché de l’Initiative des drones de défense du Canada
MiniLuxe Announces New Mansfield Studio Opening Through Joint Venture with Entrepreneur Vera Vos-Lexmond
Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
Aduro Clean Technologies fait le point sur ses activités et publie ses résultats pour le quatrième trimestre et l’exercice 2026
Aduro Clean Technologies gibt Ergebnisse für das vierte Quartal und das Geschäftsjahr 2026 bekannt und informiert über den aktuellen Geschäftsverlauf
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
Ingredient Testing Doesn't Predict a Finished Joint Supplement's Results
Oligonucleotide Drug Delivery Is Moving Beyond the Liver

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Banking

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.